GGrantIndex
← Search

PHASE I ORAL CAPECITABINE + CISPLATIN FOR ADVANCED DIGESTIVE SYSTEM CANCERS

$64,456M01FY2005RRNIH

New York University School Of Medicine, New York NY

Investigators

Linked publications & trials

View original record on NIH RePORTER →